Related Experiment Video
Updated: Jul 8, 2026
06:35
Basics of Multivariate Analysis in Neuroimaging Data
Published on: July 24, 2010
Statistical issues on the diagnostic multivariate index assay for targeted clinical trials
Jen-pei Liu1, Shein-chung Chow
1Division of Biometry, Department of Agronomy, National Taiwan University, Taipei, Taiwan. jpliu@ntu.edu.tw
Journal of Biopharmaceutical Statistics
|December 29, 2007
Summary
Pharmacogenomics and microarrays are key to personalized medicine. This study addresses challenges in in vitro diagnostic multivariate index assays (IVDMIA) and targeted clinical trials for accurate disease treatment.
Area of Science:
- Biotechnology and Bioinformatics
- Genomics and Personalized Medicine
- Clinical Diagnostics
Background:
- Pharmacogenomics and microarray technologies have advanced disease detection and treatment.
- The Human Genome Project (HGP) has spurred the development of diagnostic tests for individualized patient treatment.
- Co-development of drugs and devices is crucial for achieving personalized medicine.
Purpose of the Study:
- To identify and discuss challenges in in vitro diagnostic multivariate index assays (IVDMIA) and targeted clinical trials.
- To explore issues related to genomic composite biomarker (GCB) classifiers and their diagnostic accuracy.
- To address the validation of IVDMIA and the evaluation of effectiveness in targeted clinical trials.
Main Methods:
- Identification of key issues in IVDMIA and targeted clinical trials.
- Discussion of challenges including gene selection, GCB classifier algorithms, IVDMIA validation, and sample size estimation.
- Analysis of potential resolutions for each identified issue.
Main Results:
- Key challenges in IVDMIA include selection of differentially expressed genes and optimal GCB classifier algorithms.
- Validation of IVDMIA and accurate estimation of treatment effects in targeted trials are critical.
- Resolutions for these issues are discussed to improve diagnostic accuracy and treatment efficacy.
Conclusions:
- Addressing the identified challenges is vital for the successful implementation of personalized medicine.
- Ensuring the accuracy and precision of IVDMIA is paramount for reliable molecular target detection.
- Effective evaluation of targeted clinical trials is necessary to realize the full potential of personalized medicine.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:13Therapeutic Index
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...